Explore what becomes possible when clinical data and decisions are connected across study design, country strategy, feasibility, and site selection
Hear the Novo Nordisk + H1 story and how the organizations are working together toward a more connected clinical development ecosystem
Learn how to move beyond fragmented systems, spreadsheets, and data sources toward a trusted foundation that helps teams make faster, more informed decisions
Discover how connecting sponsor intelligence with site-level insights and feedback can strengthen feasibility and site selection while reducing disconnects across the trial lifecycle
See why connected, mastered data is critical to unlocking the potential of AI in clinical development, and why the future requires more than another point solution
Identify where Nordic R&D innovation is concentrating across therapy areas, development stages and emerging modalities
Compare Denmark, Sweden, Finland and Norway to reveal distinct innovation profiles and emerging areas of specialisation
Benchmark Nordic R&D against the global pipeline to identify where the region is over-indexing and which therapeutic areas and emerging modalities could shape the next wave of drug development
How patient centered digital measures can capture meaningful changes in health and daily life that traditional, episodic clinical assessments may miss
How continuous, real-world wearable data can help assess whether improvements during standardized in-clinic tests translate into meaningful changes in patients’ daily live
Real world case examples demonstrating how fit for purpose digital measures can reveal treatment signals, functional changes, and patient relevant outcomes that standard approaches may not fully capture
Why successful patient-centered digital measurement requires thoughtful study design, fit-for-purpose algorithms, continuous compliance monitoring, and high-quality data
Practical guidance for advancing digital measures from exploratory use toward clinically meaningful endpoints while maintaining patient relevance throughout clinical development
Exploring why, in fully outsourced clinical trial models, visibility across data systems can be less a technology question than a process one
Understanding where data signals can fall through the gaps when multiple CROs and vendors have their own internal processes, review cadences and timelines
Case study: a pharmacokinetic protocol deviation that never reached the sponsor because it fell between chairs in the communication chain
Case study: a screen failure cleaning exercise where a site misinterpretation of instructions led to an irreconcilable discrepancy
Exploring how stronger oversight frameworks and clearer agreement on what is expected, and from whom, could prevent these issues
Asking what we should be considering before adopting a new digital tool – recognising that a tool can integrate systems, but not always processes
